令和4年（2022年）論文発表 (2022.1～2022.12)
番号
著
者
名

論

文

題

名

雑

誌

名

3

Nishida S, Morimoto S, Oji Y, Morita S, Shirakata T, Enomoto T, Cellular and Humoral Immune Responses Induced by an HLA
Tsuboi A, Ueda Y, Yoshino K, Shouq A, Kanegae M, Ohno S,
Class I-restricted Peptide Cancer Vaccine Targeting WT1 Are
Fujiki F, Nakajima H, Nakae Y, Nakata J, Hosen N, Kumanogoh A, Associated With Favorable Clinical Outcomes in Advanced
Oka Y, Kimura T, Sugiyama H.
Ovarian Cancer
Shoji T, Enomoto T, Abe M, Okamoto A, Nagasawa T, Oishi T,
Efficacy and safety of standard of care with/without
Nagase S, Mori M, Inokuchi Y, Kamiura S, Komiyama S,
bevacizumab for platinum-resistant ovarian/fallopian
Takeshima N, Sugiyama T.
tube/peritoneal cancer previously treated with bevacizumab:
The Japanese Gynecologic Oncology Group study JGOG3023
Machida H, Matsuo K, Oba K, Aoki D, Enomoto T, Okamoto A,
Association between hospital treatment volume and survival of
Katabuchi H, Nagase S, Mandai M, Yaegashi N, Yamagami W,
women with gynecologic malignancy in Japan: a JSOG tumor
Mikami M.
registry-based data extraction study

4

Yagi A, Ueda Y, Ikeda S, Miyagi E, Sekine M, Enomoto T, Kimura The looming health hazard: A wave of HPV-related cancers in Lancet Reg Health West
T.
Japan is becoming a reality due to the continued suspension of Pac
the governmental recommendation of HPV vaccine

1

2

5

6

7

8

9

10

11

巻

(号)

頁

備 考

45

1

56-66

2022 Jan113

1

240-2502022 Jan

33

1

e3

2022 Jan

1003272022 JanJ Immunother

Cancer Sci

J Gynecol Oncol

Sakai K, Yamagami W, Machida H, Ebina Y, Kobayashi Y, Tabata A retrospective study for investigating the outcomes ofT, Kaneuchi M, Nagase S, Enomoto T, Aoki D, Mikami M.
endometrial cancer treated with radiotherapy

Int J Gynaecol Obstet

Ito Y, Miyoshi A, Ueda Y, Tanaka Y, Nakae R, Morimoto A,
An artificial intelligence-assisted diagnostic system improves
Shiomi M, Enomoto T, Sekine M, Sasagawa T, Yoshino K, Harada the accuracy of image diagnosis of uterine cervical lesions
H, Nakamura T, Murata T, Hiramatsu K, Saito J, Yagi J, Tanaka
Y, Kimura T.
Yamaguchi M, Nakaoka H, Suda K, Yoshihara K, Ishiguro T,
Spatiotemporal dynamics of clonal selection and diversification
Yachida N, Saito K, Ueda H, Sugino K, Mori Y, Yamawaki K,
in normal endometrial epithelium
Tamura R, Revathidevi S, Motoyama T, Tainaka K, Verhaak
RGW, Inoue I, Enomoto T.
Kurosawa M, Sekine M, Yamaguchi M, Kudo R, Hanley SJB, Hara Long-Term Effects of Human Papillomavirus Vaccination in
M, Adachi S, Ueda Y, Miyagi E, Ikeda S, Yagi A, Enomoto T.
Clinical Trials and Real-World Data: A Systematic Review

Mol Clin Oncol.

Kobayashi T, Miura K, Ishikawa H, Toge K, Hirose Y, Takizawa K, Endometrial Cancer After Pancreas-After-Kidney
Sakata J, Wakai T, Ishiguro T, Kudo R, Enomoto T, Saito K,
Transplantation: A Case Report and Review of the Literature
Tasaki M, Ikeda M, Tomita Y, Kinoshita Y.

Transplant Proc

Sugai S, Suda K, Tamegai K, Haino K, Nakatsue T, Narita I,
Enomoto T, Nishijima K.

Massive ascites due to lupus peritonitis in a patient with preeclampsia and systemic lupus erythematosus: a case report

BMC Pregnancy Childbirth

Kuji S, Harada M, Yoshioka N, Kajiyama H, Satoh T, Mikami M,
Shozu M, Enomoto T, Osuga Y, Suzuki N.

Survival and reproductive outcomes after fertility-sparing
surgery performed for borderline epithelial ovarian tumor inJapanese adolescents and young adults: Results of a
retrospective nationwide study

J Obstet Gynaecol Res

18

156

2

262-269

2022 Feb

16

2

27

2022 Feb

13

1

943

2022 Feb

10

2

256

2022 Feb

54

2560-5642022 Mar

22

1

203

2022 Mar48

3806-8162022 MarNat Commun.

Vaccines (Basel)

12

13

14

Bogani G, Ray-Coquard I, Concin N, Ngoi NYL, Morice P,
Clear cell carcinoma of the endometrium
Gynecol Oncol.
Enomoto T, Takehara K, Denys H, Lorusso D, Coleman R,
Vaughan MM, Takano M, Provencher D, Sagae S, Wimberger P,
Póka R, Segev Y, Kim SI, Kim JW, Candido Dos Reis FJ, Mariani
A, Leitao MM Jr, Makker V, Rustum NA, Vergote I, Zannoni GF,
Tan DSP, McCormack M, Bini M, Lopez S, Raspagliesi F, Panici
PB, di Donato V, Muzii L, Colombo N, Scambia G, Pignata S,
Nakano M, Shimada Y, Matsumoto Y, Saiki T, Zhou Q, Sasaki K, Efficacy of BRAF inhibitor and anti-EGFR antibody in colorectal Clin J Gastroenterol.
Moriyama M, Yoshihara K, Natsumeda M, Kuriyama Y, Takii Y,
neuroendocrine carcinoma
Watanabe G, Umezu H, Okuda S, Ikeuchi T, Wakai T, Saijo Y.
Kurosawa M, Sekine M, Yamaguchi M, Kudo R, Hanley SJB, Hara Long-term effectiveness of HPV vaccination against HPV
M, Adachi S, Ueda Y, Miyagi E, Ikeda S, Yagi A, Enomoto T.
infection in young Japanese women: Real-world data

Cancer Sci.

Tamura R, Yoshihara K, Enomoto T.

Cancers (Basel)

15

16

Shima E, Itsukaichi M, Yoshihara K, Ishiguro T, Haino K, Nishino Fetal biometric and Doppler measurements following abdominal BMC Pregnancy ChildbirthK, Nishikawa N, Nishijima K, Enomoto T.
radical trachelectomy in the second trimester of the pregnancy

Sugai S, Tsuneki I, Yanase T, Kurabayashi T
17

18

19

20

21

22

Therapeutic Strategies Focused on Cancer-AssociatedHypercoagulation for Ovarian Clear Cell Carcinoma.

Computed tomography in postpartum hemorrhage due toincomplete rupture of an unscarred uterus

Correlation between the risk of ovarian cancer and BRCA
recurrent pathogenic variants in Japan

3

658-666

2022 Mar152

413-4182022 Apr

113

4

1435-1440

2022 Apr

14

9

2125

2022 Apr

22

1

343

2022 Apr

305

4851-8532022 Apr

1023852022 May

Arch Gynecol Obstet

Monk BJ, Enomoto T, Kast WM, McCormack M, Tan DSP, Wu X, Integration of immunotherapy into treatment of cervical cancer: .
González-Martín A
Recent data and ongoing trials

Sekine M, Enomoto T, Arai M, Yokoyama S, Nomura H, Nishino
K, Ikeuchi T, Kuriyama Y, Nakamura S; Registration Committeeof the Japanese Organization of Hereditary Breast and Ovarian
Cancer.
Suzuki Y, Sukegawa A, Ueda Y, Sekine M, Enomoto T, MelamedA, Wright JD, Miyagi E.

164

106

J Hum Genet

The Effect of a Web-Based Cervical Cancer Survivor's Story on JMIR Public HealthParents' Behavior and Willingness to Consider Human
Surveill.
Papillomavirus Vaccination for Daughters: Randomized
Controlled Trial
Egawa-Takata T, Ueda Y, Ito K, Hori K, Tadahiro S, Nagasawa T, Adjuvant Chemotherapy for Endometrial Cancer (ACE) trial: A
Cancer Sci
Nishio S, Ushijima K, Koji N, Enomoto T, Kikuchi A, Honma S,
randomized phase II study for advanced endometrial carcinoma
Oishi T, Shimada M, Takei Y, Fujiwara H, Tanabe H, Okamoto A,
Nishio Y, Yamada T, Kimura T.
Kobayashi E, Nakatani E, Tanaka T, Yosuke K, Kanao H, Shiki Y, Surgical skill and oncological outcome of laparoscopic radical
Gynecol Oncol
Kotani Y, Hoshiba T, Minami R, Yoshida H, Kyo S, Yorimitsu M, hysterectomy: JGOG1081s-A1, an ancillary analysis of the
Yamashita T, Hasegawa T, Matsuura T, Kagami S, Fujioka T,
Japanese Gynecologic Oncology Group Study JGOG1081
Hirohiko T, Nishio S, Takekuma M, Mikami M, Enomoto T.

67

5267-2722022 May

85e347152022 May

113

51693-1701

2022 May

1652

293-301

2022 May

23

24

25

26

Yoshida H, Kikuchi A, Tsuda H, Sakamoto A, Fukunaga M, Kaku
T, Yoshida M, Shikama A, Kogata Y, Terao Y, Tanikawa M,
Yasuoka T, Chiyoda T, Miyamoto T, Okadome M, Nakamura T,
Enomoto T, Konno Y, Yahata H, Hirata Y, Aoki Y, Tokunaga H,
Usui H, Yaegashi N.
Revathidevi S, Nakaoka H, Suda K, Fujito N, Munirajan AK,
Yoshihara K, Enomoto T, Inoue I.

Discrepancies in pathological diagnosis of endometrial stromal
sarcoma: a multi-institutional retrospective study from theJapanese Clinical Oncology Group

Hum Pathol.

APOBEC mediated mutagenesis drives genomic heterogeneity
in endometriosis

J Hum Genet.

124

Yano M, Nasu K, Yasuda M, Katoh T, Kagabu M, Kobara H,
Clinicopathological features and programmed death-ligand 1
Melanoma Res
Matsuura M, Tokuyama O, Yamawaki T, Wakahashi S, Noguchi T, immunohistochemical expression in a multicenter cohort of
Mizuno K, Shitsukawa K, Onohara Y, Nakabori T, Miyasaka A,
uterine and ovarian melanomas: a retrospective study in Japan
Nakao T, Matsunaga T, Kunimi Y, Sakurai M, Uchiyama A, Itoh R, (KCOG-G1701s)
Ohike N, Hirakawa T, Watanabe T, Nishino K, Motohashi T, Ito K.
Matsuo K, Nishio S, Ogata D, Kato T, Matsuura M, Mikami M,
Treatment specialty-specific characteristics and outcomes in
J Surg Oncol
women with vulvo-vaginal melanoma: A JGOG-JSCS joint study
Enomoto T.

Cancer Sci

27

Kudo R, Sekine M, Yamaguchi M, Hara M, Hanley SJB, Kurosawa Effectiveness of human papillomavirus vaccine against cervical
M, Adachi S, Ueda Y, Miyagi E, Ikeda S, Yagi A, Enomoto T.
precancer in Japan: Multivariate analyses adjusted for sexual
activity
Enomoto S, Yoshihara K, Kondo E, Iwata A, Tanaka M, Tabata T, Trends in Pregnancy-Associated Cervical Cancer in Japan
Kudo Y, Kondoh E, Mandai M, Sugiyama T, Okamoto A, Saito T, between 2012 and 2017: A Multicenter Survey
Enomoto T, Ikeda T.

Cancers (Basel)

28

Tanigawa T, Takeshima N, Ishikawa H, Nishio S, Usami T,
Yamawaki T, Oishi T, Ihira K, Kato H, Goto M, Saito M, Taira Y,
Yokoyama M, Shoji T, Kondo E, Mori A, Yokoi T, Iwasa-Inoue N,
Hirashima Y, Nagasawa T, Takenaka M, Mikami M, Sugiyama T,
ET
Sugai S, Haino
K, Yamawaki K, Nishijima K, Enomoto T.

Gynecol Oncol

29

30

Paclitaxel-carboplatin and bevacizumab combination withmaintenance bevacizumab therapy for metastatic, recurrent,
and persistent uterine cervical cancer: An open-label
multicenter phase II trial (JGOG1079)
Spontaneous healing of uterine rupture causing postpartum
hemorrhage

31

Asano H, Oda K, Yoshihara K, Ito YM, Matsumura N, Shimada M, Phase II study of niraparib in recurrent or persistent rare
Watari H, Enomoto T.
fraction of gynecologic malignancies with homologous
recombination deficiency (JGOG2052)

32

Sekine M, Enomoto T, Arai M, Den H, Nomura H, Ikeuchi T,
Nakamura S; Registration Committee of the Japanese
Organization of Hereditary Breast and Ovarian Cancer.

33

Sekine M, Nishijima K, Nakagawa S, Suzuki Y, Murakami T, Kato Challenges facing workstyle reform for Japanese obstetricians
Y, Umazume T, Tanaka H, Komatsu H, Doi K, Miura K, Kudo Y,
and gynecologists revealed from time studies
Unno N, Kimura T, Enomoto T.

Eur J Obstet Gynecol
Reprod Biol

24-35

2022 Jun

676323-3292022 Jun32

3150-158

2022 Jun

125

8

1333–1337

2022 Jun113

93211-3220

2022 Jun

14

13

3072

2022 Jun

165

3

413-4192022 Jun

255-2572022 Jul274

J Gynecol Oncol

Differences in age at diagnosis of ovarian cancer for each BRCA J Gynecol Oncol
mutation type in Japan: optimal timing to carry out riskreducing salpingo-oophorectomy

33

4

e55

2022 Jul

33

4

e46

2022 Jul48

7

1580-1590

2022 JulJ Obstet Gynaecol Res

34

35

36

37

38

Vestal NL, Sangara RN, Mandelbaum RS, Matsuzaki S, McCarthy Racial and ethnic disparity in characteristics and outcomes ofLE, Matsushima K, Yoshihara K, Klar M, Lee RH, Ouzounian JG, women with placenta accreta spectrum: a comparative study
Matsuo K.

Reprod Sci.

Sekine M, Yamaguchi M, Kudo R, Hanley SJB, Ueda Y, Kurosawa Problems with catch-up HPV vaccination after resumption ofM, Adachi S, Miyagi E, Hara M, Enomoto T.
proactive recommendations

Lancet Oncol

Chiyoda T, Yoshihara K, Kagabu M, Nagase S, Katabuchi H,
Mikami M, Tabata T, Hirashima Y, Kobayashi Y, Kaneuchi M,
Tokunaga H, Baba T.

Sentinel node navigation surgery in cervical cancer: asystematic review and metaanalysis

Int J Clin Oncol.

Pujade-Lauraine E, Tan DSP, Leary A, Mirza MR, Enomoto T,
Takyar J, Nunes AT, Chagüi JDH, Paskow MJ, Monk BJ.

Comparison of global treatment guidelines for locally advanced
cervical cancer to optimize best care practices: A systematicand scoping review

Gynecol Oncol

Yagi A, Ueda Y, Nakagawa S, Ikeda S, Kakuda M, Hiramatsu K,
Miyoshi A, Kobayashi E, Kimura T, Mizushima T, Suzuki Y,
Sekine M, Hirai K, Nakayama T, Miyagi E, Enomoto T, Kimura T.

Can Catch-Up Vaccinations Fill the Void Left by Suspension of Vaccines (Basel)
the Governmental Recommendation of HPV Vaccine in Japan?

Sugai S, Nishijima K.

Validating a calculator without race and ethnicity to predictvaginal birth after cesarean delivery

39

40

41

42

Cancer Sci

43

Kudo R, Sekine M, Yamaguchi M, Hara M, Hanley SJB, Kurosawa Effectiveness of human papillomavirus vaccine against cervical
M, Adachi S, Ueda Y, Miyagi E, Ikeda S, Yagi A, Enomoto T.
precancer in Japan: Multivariate analyses adjusted for sexual
activity
Zanotti-Fregonara P, Ishiguro T, Yoshihara K, Ishii S, Enomoto
T.

J Nucl Med.

44

1988-2000

2022 Jul238

972-9732022 Aug27

81247-1255

2022 Aug

S00908258

2200552-2

2022 Sep

10

9

1455

2022 Sep

227

3537-5382022 Sep

33

5

e61

2022 Sep306

3865-874

2022 Sep

22

1

706

2022 Sep

113

93211-3220

2022 Sep

63

10

1592-1597

2022 OctBMC Pregnancy ChildbirthUnexpected uterine body placenta accreta spectrum withplacenta previa in a subsequent pregnancy after uterine artery
embolization: a case report

18 F-FDG Fetal Dosimetry Calculated with PET/MRI

7

Am J Obstet Gynecol.

Kobayashi Y, Masuda K, Hiraswa A, Takehara K, Tsuda H,
Current status of hereditary breast and ovarian cancer practice J Gynecol Oncol
Watanabe Y, Oda K, Nagase S, Mandai M, Okamoto A, Yaegashi among gynecologic oncologists in Japan: a nationwide survey by
N, Mikami M, Enomoto T, Aoki D, Katabuchi H; Working Group on the Japan Society of Gynecologic Oncology (JSGO)
Clinical Practice for Cancer Genomic Medicine and HBOC,
Japan Society of Gynecologic Oncology.
Matsuo K, Mandelbaum R, Deshpande RR, Nusbaum DJ,
Population incidence and characteristics of secondary breast
Arch Gynecol Obstet
Yoshihara K, Machida H, Bainvoll L, Matsuzaki S, Klar M, Roman cancer after uterine cancer: a competing risk analysis
LD, Wright JD.
Sugai S, Yamawaki K, Haino K, Nishijima K.

29

45

Yagi A, Ueda Y, Nakagawa S, Ikeda S, Kakuda M, Hiramatsu K,
Miyoshi A, Kobayashi E, Kimura T, Hirai K, Nakayama T, Miyagi
E, Sekine M, Enomoto T, Kimura T.

Change of HPV vaccination rates in Japan: the effect ofindividual notifications implemented by local governments

Ueda A, Watari H, Mandai M, Fukuhara S, Sugitani Y, Ogino K,
Kamijima S, Enomoto T.

J Gynecol Oncol
Incidence of gastrointestinal perforation associated with
bevacizumab in combination with neoadjuvant chemotherapy as
first-line treatment of advanced ovarian, fallopian tube, or
peritoneal cancer: analysis of a Japanese healthcare claims
database
Factor structure of the parental bonding instrument for
Sci Rep.
pregnant Japanese women46
Fukui N, Watanabe Y, Hashijiri K, Motegi T, Ogawa M, Egawa J,
Enomoto T, Someya T.

Int J Clin Oncol

47
Hum Vaccin Immunother48

Hiramatsu K, Ueda Y, Yagi A, Morimoto A, Egawa-Takata T,
The efficacy of human papillomavirus vaccination in young
Nakagawa S, Kobayashi E, Kimura T, Kimura T, Minekawa R, Hori Japanese girls: the interim results of the OCEAN study
Y, Sato K, Morii E, Nakayama T, Tanaka Y, Terai Y, Ohmichi M,
Ichimura T, Sumi T, Murata H, Okada H, Nakai H, Matsumura N,
Mandai M, Saito J, Horikoshi Y, Takagi T, Enomoto T, Shimura K.

Int J Gynecol Cancer

49

Bogani G, Ray-Coquard I, Concin N, Ngoi NYL, Morice P, Caruso Endometrial carcinosarcoma
G, Enomoto T, Takehara K, Denys H, Lorusso D, Coleman R,
Vaughan MM, Takano M, Provencher DM, Sagae S, Wimberger P,
Póka R, Segev Y, Kim SI, Kim JW, Candido Dos Reis FJ, Ramirez
PT, Mariani A, Leitao M, Makker V, Abu-Rustum NR, Vergote I,
Zannoni G, Tan D, McCormack M, Paolini B, Bini M, Raspagliesi
F, Benedetti Panici P, Di Donato V, Muzii L, Colombo N, Pignata
S, Scambia G, Monk BJ.

50

51

八木 麻未, 上田 豊, 池田 さやか, 宮城 悦子, 関根 正幸, 榎本
隆之, 木村 正

HPVワクチンの積極的勧奨差し控えによって上昇した2000年度 Journal of Epidemiology
生まれの子宮頸部細胞診異常率

松本賢典、五日市美奈、生野寿史、西島浩二、榎本隆之、荒井勇樹、庄司圭介

妊娠第３三半期に現れた側胸腹部体表に発生した稀な胎児 新潟産科婦人科学会誌
lymphatic malformationの１例

松本賢典、能仲太郎、西島浩二、榎本隆之

妊娠30週で子宮内胎児死亡に至り、HELLP症候群を発症した16 新潟産科婦人科学会誌
トリソミー胎盤性モザイクと考えられた１例

52
榎本 隆之
53

日本産科婦人科学会が提唱する方向性 サステイナブル産婦人 産婦人科の実際
科医療体制確立委員会の活動報告

27101651-1659

2022 Oct

33

6

e78

2022 Nov

12

1

19071

2022 Nov

18

1

1951098

2022 Decdoi:
10.1136/ijgc2022004073.

2022 Dec32

Suppl.1

1062022.01

116

1

1-5

2022.1

116

1

6-10

2022.171

1

1-82022.01

西島 浩二, 中川 慧, 榎本 隆之

タイムスタディから浮かび上がる医師の働き方2024年問題

産婦人科の実際

54
松本 賢典, 西島 浩二

会陰裂傷

卵巣癌に対するHBOCの診断と治療

56
西野 幸治, 関根 正幸, 榎本 隆之
57
工藤 梨沙, 関根 正幸, 榎本 隆之

遺伝子医学
別冊遺伝性腫瘍の基礎知
識

遺伝性疾患としての病態,診断法,治療ないし対応法と説明の際の留意点

臨床婦人科産科

HPVワクチンの最新の話題

ペリネイタルケア

58
石黒 竜也
59
磯部真倫
60

61

62

63

64

がん幹細胞モデルを基盤としたがんの不均一性を考慮した個別 日本産科婦人科学会雑誌
化医療への展開

オンラインによる医療者教育 Vol.21 オンラインによるFaculty
Development-Zoom教育事例検討会

工藤 梨沙, 関根 正幸, 黒澤 めぐみ, 山口 真奈子, 安達 聡介, 榎 HPVワクチン積極的勧奨再開へ向けて
本 隆之

1

27-32

2022.01

51

増刊

332-333

2022.01

108-1122022.01

周産期医学55
関根 正幸, 西野 幸治, 榎本 隆之

71

別冊

76

1

88-95

2022.01412

173-1772022.0274

臨増

S10-132022.02280

121254-1260

2022.03

864

10-15

2022.03

116

2

65

2022.03

116

2

62

2022.03

116

2

58

2022.03

医学のあゆみ新潟県医師会報

渡部 はるか, 小林 暁子, 安田 麻友, 黒澤 めぐみ, 齋藤 宏美, 鈴 子宮頸部筋腫に対する腹腔鏡下単純子宮全摘術 側方処理のメ 新潟産科婦人科学会会誌
木 美保, 工藤 梨沙, 田村 亮, 島 英里, 石黒 竜也, 安達 聡介, 吉 ルクマール
原 弘祐, 磯部 真倫, 西野 幸治, 山口 雅幸, 西川 伸道, 関根 正
幸, 榎本 隆之
安田 麻友, 小林 暁子, 黒澤 めぐみ, 齋藤 宏美, 鈴木 美保, 工藤 腹腔鏡下仙骨腟固定術術後再発に関する検討
新潟産科婦人科学会会誌
梨沙, 田村 亮, 島 英里, 石黒 竜也, 安達 聡介, 吉原 弘祐, 磯部真倫, 西野 幸治, 山口 雅幸, 西川 伸道, 関根 正幸, 榎本 隆之
黒澤 めぐみ, 西野 幸治, 安田 麻友, 明石 絵里菜, 齋藤 宏美, 鈴 腟式子宮全摘術後にリスク低減卵管卵巣摘出術を施行した一例 新潟産科婦人科学会会誌
木 美保, 工藤 梨沙, 田村 亮, 島 英里, 須田 一暁, 石黒 竜也, 安達 聡介, 吉原 弘祐, 磯部 真倫, 小林 暁子, 山口 雅幸, 西川 伸
道, 関根 正幸, 榎本 隆之

65

黒澤 めぐみ, 西野 幸治, 武藤 恵里, 明石 絵里菜, 齋藤 宏美, 谷 当院における保険適応下のリスク低減卵管卵巣摘出術(RRSO)
地田 希, 鈴木 美保, 工藤 梨沙, 須田 一暁, 石黒 竜也, 南川 高 の導入と実施状況
廣, 安達 聡介, 吉原 弘祐, 磯部 真倫, 小林 暁子, 西川 伸道, 関
根 正幸, 榎本 隆之, 利川 千絵, 諸 和樹, 池内 健, 入月 浩美, 栗山洋子 藤田 沙緒里
工藤梨沙、関根正幸、榎本隆之
H P Vワクチンの積極的勧奨再開

新潟産科婦人科学会会誌

腹腔鏡下手術TLH/LMにおける縫合・結紮の基本とコツ

68
生野寿史, 西島浩二

遺伝子診断 BRCA遺伝学的検査とはどのような検査か,何がわ 臨床婦人科産科
かるか

胎児の発育

臨床におけるバイオインフォマティクス

HPVワクチン有効性のエビデンス 新潟スタディ

下腹部痛で卵巣腫大があれば卵巣腫瘍茎捻転?

吉原弘祐

明石 絵里菜, 吉原 弘祐, 関根 正幸

婦人科癌治療における個別化医療の実現に向けて がんゲノム 日本婦人科腫瘍学会雑誌
医療拠点病院における個別化医療実践に向けた取り組み

肝臓疾患を有する婦人科がん患者の留意点

75

HPVワクチンに関する最新の情報

2022

89

4

381-3862022.04763

317-3222022.04524

438-4422022.04281

131239-1244

2022.06

896

623-6272022.065981360-1363

2022.0740

3

112-1192022.07718

849-8542022.08

597

34-41

2022

産婦人科の実際

74
工藤梨沙、関根正幸、榎本隆之

2-4

Medicina

72

73

4

産科と婦人科

71
磯部 真倫

30

医学のあゆみ70
工藤梨沙, 関根正幸, 榎本隆之

2022.03

周産期医学69
吉原 弘祐, 須田 一暁, 榎本 隆之

57

産科と婦人科67
西野 幸治, 西川 伸道, 関根 正幸, 榎本 隆之

2

JGOG newsletter66
堀澤信、黒田浩、磯部真倫

116

柏崎市医師会会報黒澤 めぐみ, 山口 真奈子, 工藤 梨沙, 関根 正幸, 榎本 隆之
76
榎本 隆之, 増山 寿, 中川 慧

HPVワクチンの有効性 2価・4価ワクチンを使用した日本・海外における臨床データ

臨床婦人科産科「医師の働き方改革」と学会の現在地

臨床婦人科産科

77
吉原弘祐
78
西島浩二

正常子宮内膜のゲノム異常に注目した子宮内膜関連疾患の発症メカニズムの解明

日本産科婦人科学会雑誌

医師の働き方改革と新潟県の周産期医療の未来

新潟県医師会報

768

754-7612022.08768

808-8142022.0874

91397-1404

2022.09871

010-142022

121211-1220

2022

79
西島浩二

前置癒着胎盤の帝王切開・Cesarean hysterectomy

臨床婦人科産科

8076
鈴木研裕，髙見秀樹，磯部真倫

外科系志望の医師を増やす戦略

81

82

松本賢典, 関塚智之, 山脇芳, 生野寿史, 田中雅人, 楡井淳, 小林玲, 西島浩二

在胎36-38週における新生児呼吸障害例の検討 ～Lamellar
body countを指標として～

日本周産期・新生児医学会雑誌

登内恵里子, 山脇芳, 生野寿史, 西島浩二

子宮頸管熟化不全に対するジノプロストン腟用剤と器械的熟化法の有用性の比較検討

日本周産期・新生児医学会雑誌83
今井諭, 山脇芳, 生野寿史, 西島浩二
84
西島浩二
85

週刊医学界新聞（レジデント号）

当院で周産期管理を行った胎児先天性消化管閉鎖52症例の臨 日本周産期・新生児医学
床的検討
会雑誌

前置癒着胎盤―子宮底部横切開法

2022.11

3493

58

3

492-4972022.12583498-5032022.12583

510-5152022.1252

121731-17352022

周産期医学